Liver cirrhosis

Abstract

The liver cirrhosis (LC) is a severe disease, the 11^th by the cause of death in the world, 50 % of patients die during 5 years. The most frequent etiological factors are alcoholic disease of the liver and chronic viral hepatitis. The following general pathological mechanisms are involved in LC pathogenesis: hepatocyte damage, endothelial dysfunction, oxidant stress, fibrosis activation, pathological regeneration, neoangiogenesis, architectonic impairment of the organ with the development of portal hypertension. Genetic factors contribute to the progression of the liver pathology. Depending on the LC etiology, there are the features of pathogenesis, clinical picture, morphology, diagnostics, treatment and prognosis for alcoholic liver disease, chronic viral hepatitis, nonalcoholic fat liver disease, autoimmune hepatitis, primary biliary LC, hemochromatosis, Wilson-Konovalov disease, A1-antitripcin deficiency disease. Among rare causes of LC, there are noted Budd-Chiari syndrome, cardiac cirrhosis, Indian childhood cirrhosis.

Keywords

liver cirrhosis / etiology, pathogenesis / hepatic syndrome in liver cirrhosis / features of cirrhosis of different etiology

References

[1] Moon A.M., Singal A.G., Tapper E.B. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin. Gastroenterol. Hepatol. 2020; 18 (12): 2650–2666.

[2] The Burden of Liver Disease in Europe. EASL, 2013, available at: https://easl.eu/wp-content/uploads/2018/09/EASL-HEPAHEALTH-Report.pdf

[3] The Burden of Liver Disease in Europe. EASL, 2013, available at: https://easl.eu/wp-content/uploads/2018/09/EASL-HEPAHEALTH-Report.pdf.

[4] Ivashkin V.T., Maevskaya M.V., Pavlov CH., Bessonova E.N., Pirogova I.YU., Garbuzenko D.V. Clinical guidelines of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the treatment of complications of liver cirrhosis. Russian journal of gastroenterology, hepatology, coloproctology. 2016; 26 (4): 71–102 (in Russian).

[5] Ивашкин В.Т., Маевская М.В., Павлов Ч.С., Бессонова Е.Н., Пирогова И.Ю., Гарбузенко Д.В. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2016; 26 (4): 71–102.

[6] SHerlok S.H., Duli Dzh. Diseases of the liver and biliary tract: Practical. hands: Per. from English. Ed. Z.G. Aprosina, N.A. Mukhin. Moscow: GEOTAR-MED 2002; 864 (in Russian).

[7] Шерлок Ш., Дули Дж. Заболевания печени и жёлчных путей: практич. рук. Пер. с англ. Под ред. З.Г. Апросиной, Н.А. Мухина. М.: ГЭОТАР-МЕД 2002; 864.

[8] Kisseleva T., Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 2018; 18: 151–166.

[9] SHCHyokotova A.P. Clinical and laboratory indicators and endothelial dysfunction in liver diseases, their diagnostic, prognostic significance and the possibility of using to assess the effectiveness of therapy: author. dis. … dr. med. sciences. Perm. 2012; 49 (in Russian).

[10] Щёкотова А.П. Клинико-лабораторные показатели и эндотелиальная дисфункция при заболеваниях печени, их диагностическая, прогностическая значимость и возможность использования для оценки эффективности терапии: автореф. дис. … д-ра мед. наук. Пермь 2012; 49.

[11] Bulatova I.A. Fibrosis in chronic liver diseases: mechanisms of development, clinical and laboratory evaluation of progression and monitoring of therapy: author's abstract. dis. … dr. med. sciences. Perm. 2016; 49 (in Russian).

[12] Булатова И.А. Фиброз при хронических заболеваниях печени: механизма развития, клинико-лабораторная оценка прогрессирования и мониторинг терапии: автореф. дис. … д-ра мед. наук. Пермь 2016; 49.

[13] WHO. Hepatitis B, available at: https:// www.who.int/news-room/fact-sheets/detail/ hepatitis-b

[14] WHO. Hepatitis C, available at: https:// www.who.int/news-room/fact-sheets/detail/ hepatitis-c

[15] WHO. Hepatitis C, available at: https://www.who.int/news-room/fact-sheets/ detail/hepatitis-c

[16] Huang H., Shiffman M.L., Friedman S., Venkatesh R., Bzowej N., Abar O.T., Rowland C.M., Catanese J.J., Leong D.U., Sninsky J.J. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007; 46: 297–306.

[17] Huang H., Shiffman M.L., Friedman S., Venkatesh R., Bzowej N., Abar O.T., Rowland C.M., Catanese J.J., Leong D.U., Sninsky J.J. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007; 46: 297–306.

[18] Ivashkin V.T. Diseases of the liver and biliary tract. Guide for doctors. 2nd ed. Moscow: Publishing house. House "M-Vesti" 2005; 536 (in Russian).

[19] Ивашкин В.Т. Болезни печени и желчевыводящих путей: руководство для врачей. 2-е изд. М.: М-Вести 2005; 536.

[20] EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. European Association for the Study of the Liver. Journal of Hepatology 2012; 57: 399–420.

[21] Alkogol'naya bolezn' pecheni. Klinicheskie rekomendacii MZ RF. Nauchnoe obshchestvo gastroenterologov Rossii – Rossijskoe nauchnoe medicinskoe obshchestvo terapevtov. 2019: 38, available at: https://www.rnmot.ru/ public/uploads/RNMOT/ (in Russian)

[22] Алкогольная болезнь печени. Клинические рекомендации МЗ РФ. Научное общество гастроэнтерологов России – Российское научное медицинское общество терапевтов. 2019: 38, available at: https://www. rnmot.ru/public/uploads/RNMOT/

[23] Ivashkin V.T., Maevskaya M.V., Pavlov CH.S., Sivolap YU.P., Lun'kov V.D., ZHarkova M.S., Maslennikov R.V. Clinical guidelines of the Russian Society for the Study of the Liver for the management of adult patients with alcoholic liver disease. Russian journal of gastroenterology, hepatology, coloproctology 2017; 27 (6): 20–40 (in Russian).

[24] Ивашкин В.Т., Маевская М.В., Павлов Ч.С., Сиволап Ю.П., Луньков В.Д., Жаркова М.С., Масленников Р.В. Клинические рекомендации Российского общества по изучению печени по ведению взрослых пациентов с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017; 27 (6): 20–40.

[25] EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Journal of Hepatology 2018; (69): 154–181.

[26] EASL Clinical Practice Guidelines: Management of alcohol-related liver disease Journal of Hepatology 2018; (69): 154–181.

[27] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. European Association for the Study of the Liver. J of Hepatology 2018; (57): 399–420.

[28] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. European Association for the Study of the Liver. J of Hepatology. 2018; (57): 399–420.

[29] Klinicheskie rekomendacii EASL–EASD–EASO po diagnostike i lecheniyu nealkogol'noj zhirovoj bolezni pecheni. J of Hepatology 2016; (64): 1388–1402 (in Russian).

[30] Клинические рекомендации EASL–EASD–EASO по диагностике и лечению неалкогольной жировой болезни печени. J of Hepatology. 2016; (64): 1388–1402.

[31] EASL Clinical Practice Guidelines: Autoimmune hepatitis. European Association for the Study of the Liver. J of Hepatology 2015; (63): 971–1004.

[32] EASL Clinical Practice Guidelines: Auto-immune hepatitis. European Association for the Study of the Liver. J of Hepatology 2015; (63): 971–1004.

[33] EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J of Hepatology 2017; (67): 145–172.

[34] EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J of Hepatology. 2017; (67): 145–172.

[35] Ivashkin V.T., SHirokova E.N.Yu Maevskaya M.V., Pavlov CH.S., SHifrin O.S., Maev I.V., Truhmanov A.S. Clinical recommendations of the Russian Gastro-enterological Association and the Russian Society for the Study of the Liver for the diagnosis and treatment of cholestasis. RZHGGK. 2015; 2: 41–57 (in Russian).

[36] Ивашкин В.Т., Широкова Е.Н. Маевская М.В., Павлов Ч.С., Шифрин О.С., Маев И.В., Трухманов А.С. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени, по диагностике и лечению холестаза. РЖГГК. 2015; 2: 41–57.

[37] Deepak Marwach. Complete Review of Medicine for NBE. Fourth Edition: 2018. CBS Publishers s Distributions Pvt Ltd. Delhi, India 2018; 925.

RIGHTS & PERMISSIONS

Shchyokotova A.P.